Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Cost of Goods Sold

Arcus Biosciences Inc Cost of Goods Sold Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Cost of Goods Sold from 2017 to 2018.
  • Arcus Biosciences Inc Cost of Goods Sold for the quarter ending December 12, 2018 was $-38m a 130.49% decrease of -50m year over year
  • Arcus Biosciences Inc Cost of Goods Sold for the last 12 months ending September 09, 2018 was $50m a 6.23% increase of 3m year over year
  • Arcus Biosciences Inc Annual Cost of Goods Sold for 2017 was $47m a 69.83% increase of 33m from 2016
  • Arcus Biosciences Inc Annual Cost of Goods Sold for 2016 was $14m
Other Income Statement Metrics:
  • Arcus Biosciences Inc EBITDA for the quarter ending December 12, 2018 was $-13m a 0.27% decrease of 0m year over year
  • Arcus Biosciences Inc Net Income for the quarter ending December 12, 2018 was $-12m a -5.36% increase of 1m year over year
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS Cost of Goods Sold Data

12/2018$-38m
09/2018$13m
06/2018$14m
03/2018$12m
12/2017$-35m
09/2017$21m
06/2017$8m
03/2017$6m

Annual RCUS Cost of Goods Sold Data

2017$47m
2016$14m